Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002 May 04; 359(9317):1541-9.
View in:
PubMed
subject areas
Adult
Aged
Analysis of Variance
Antibodies, Monoclonal
Chi-Square Distribution
Crohn Disease
Cross-Over Studies
Double-Blind Method
Female
Gastrointestinal Agents
Humans
Infliximab
Infusions, Intravenous
Male
Middle Aged
Remission Induction
Treatment Outcome
authors with profiles
Stephen B. Hanauer